Education
About Us
Working with TipRanks
Follow Us
Soligenix (SNGX)
NASDAQ:SNGX
SNGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.68 - $14.83
Previous CloseN/A
Volume55.16K
Average Volume (3M)20.75K
Market Cap
$5.88M
Enterprise Value$22.80M
Total Cash (Recent Filing)$7.82M
Total Debt (Recent Filing)$1.48M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Aug 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.06
Shares Outstanding3,264,346
10 Day Avg. Volume26,179
30 Day Avg. Volume20,751
Financial Highlights & Ratios
PEG Ratio-0.56
Price to Book (P/B)-7.87
Price to Sales (P/S)0.00
P/FCF Ratio-1.54
Enterprise Value/Market Cap3.88
Enterprise Value/Revenue13.54
Enterprise Value/Gross Profit-14.36K
Enterprise Value/Ebitda-0.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
PremiumCompany Announcements
Soligenix Reports Q1 2025 Financial Results and Milestones
PremiumCompany Announcements
Soligenix Repays Loan, Boosting Financial FlexibilityOptions Prices
Currently, No data available
---
Ownership Overview
14.20%
Insiders
0.80% Mutual Funds
3.12% Other Institutional Investors
81.78% Public Companies and Individual Investors
SNGX FAQ
What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $1.68 and its highest was $14.83 in the past 12 months.
What is Soligenix’s market cap?
Soligenix’s market cap is $5.88M.
When is Soligenix’s upcoming earnings report date?
Soligenix’s upcoming earnings report date is Aug 08, 2025 which is in 52 days.
How were Soligenix’s earnings last quarter?
Soligenix released its earnings results on May 09, 2025. The company reported -$1.06 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.06.
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Overvalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Soligenix have?
Soligenix has 3,264,346 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Soligenix reported an EPS of -$1.06 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.508%.
Which hedge fund is a major shareholder of Soligenix?
Currently, no hedge funds are holding shares in SNGX
Company Description
Soligenix
Soligenix, Inc. (SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company's core sectors include biotherapeutics and public health solutions. Within biotherapeutics, it is engaged in the development of specialized drug products for oncology, inflammation, and biodefense. Soligenix's lead product candidates include SGX301, a novel photodynamic therapy for cutaneous T-cell lymphoma, and SGX942, an innate defense regulator for the treatment of oral mucositis in head and neck cancer patients.